PREZERV
The fertility side of TRT

hCG vs enclomiphene: which one actually protects fertility on TRT?

Updated July 21, 2026 · 6 min read

The question of hCG vs enclomiphene comes up constantly for men trying to protect fertility while dealing with low testosterone. Both drugs are real tools, but they work through completely different pathways, and one of them simply does not work if you are still on testosterone. Getting this wrong costs you months. Here is the honest breakdown.

How each drug actually works

hCG is a structural mimic of LH. When you inject it, it binds directly to LH receptors on the Leydig cells inside your testes and tells them to keep making testosterone and to keep the environment that supports sperm production. It bypasses the pituitary entirely. Your brain can be completely shut down by exogenous testosterone, and hCG still works, because it is delivering the signal locally at the target organ.

Enclomiphene works in the opposite direction. It blocks estrogen receptors at the hypothalamus and pituitary, which removes the negative feedback signal that estrogen normally sends. With that brake released, your pituitary starts pumping out more LH and FSH on its own. That is a clean, elegant mechanism, but it has one absolute requirement: your pituitary has to be awake and able to respond. If you are on exogenous testosterone, your entire hypothalamic-pituitary-gonadal axis is suppressed. Enclomiphene has nothing to unblock, because the axis is not receiving any signal worth amplifying in the first place.

Why SERMs don't work while you're still on TRT

TRT suppresses LH and FSH to roughly 3 to 5 percent of normal levels, and intratesticular testosterone drops by about 94 percent. (Coviello 2005) That is the mechanism that makes testosterone an effective contraceptive. When someone is that deeply suppressed, a SERM like enclomiphene or clomiphene cannot generate a meaningful LH or FSH response, because the testosterone you are injecting is continuously overriding the hypothalamic signal regardless of what the estrogen receptors are doing. This is not a theoretical concern. It is why clinical guidelines explicitly place SERMs as therapies used after TRT or instead of it, not alongside it. (BSSM 2025)

hCG has no such limitation. Because it acts directly on the testes, it can keep intratesticular testosterone in the normal range even when the pituitary is completely silent. Studies show that low-dose hCG at 250 to 500 IU every other day is enough to preserve that intratesticular environment, and 500 IU every other day specifically preserved sperm production in men on exogenous testosterone. (Coviello 2005; Hsieh 2013) So if staying on TRT is the plan and protecting fertility matters, hCG is the only one of these two options that can actually do the job.

When enclomiphene is the better choice

Enclomiphene is genuinely useful in two situations: as a stand-alone treatment for men with secondary hypogonadism who have not started TRT yet, or as part of a recovery protocol after coming off testosterone. In both cases the axis is not being suppressed by exogenous androgens, so the pituitary can actually respond to the estrogen-receptor blockade. Enclomiphene raises your own LH and FSH, which then drives both testicular testosterone production and sperm production simultaneously. For a man who wants to raise testosterone while keeping fertility intact and who has not yet started TRT, this approach has real appeal.

The tradeoff is that enclomiphene depends entirely on your pituitary functioning well enough to respond, and it does not give you the same degree of hormonal control that TRT does. Symptom relief tends to be more variable. For men whose primary goal is conceiving in the near term and who can tolerate their natural testosterone levels, enclomiphene or other SERMs are worth a serious conversation with a urologist or reproductive endocrinologist before committing to TRT.

hCG instead of TRT: a third path worth knowing

Some men ask about using hCG instead of TRT altogether, rather than adding it on top. Because hCG stimulates the testes to make their own testosterone, it can raise serum testosterone in men with secondary hypogonadism, the kind where the problem is a lack of LH signal rather than a failure of the testes themselves. The appeal is obvious: you keep the testes active, you keep sperm production running, and you avoid the deep suppression that comes with exogenous testosterone.

The practical limitations are real though. hCG alone does not work for primary hypogonadism, where the testes themselves are the problem. Injections are frequent. And hCG drives the LH pathway but does not directly stimulate FSH-dependent sperm production the way FSH itself does. For men where sperm output is the priority, clinicians often add an FSH-containing medication (HMG or recombinant FSH, typically around 75 IU two to three times per week) alongside hCG, because FSH is what directly drives spermatogenesis. That combination induces sperm production in roughly 80 percent of men with hypogonadotropic hypogonadism, with pregnancy rates around 50 percent. (Rastrelli/Corona 2019) Whether hCG monotherapy, hCG plus FSH, or TRT with hCG makes the most sense for a given man is genuinely a clinical decision, not a forum one.

The practical decision tree

If you are currently on TRT and want to protect or restore fertility, hCG is the tool that can actually work right now. Enclomiphene will not do anything meaningful while exogenous testosterone is suppressing your axis. If you are not yet on TRT and your main concern is preserving fertility while addressing low-T symptoms, enclomiphene is worth discussing before you start, because starting TRT shuts things down and recovery, while likely, takes time. Median sperm recovery after stopping testosterone is around 3.4 months to reach a fertile threshold, with about 90 percent of men recovering by 12 months, but that is 3 to 12 months you are waiting. (Liu 2006)

It is also worth remembering that sperm take 64 to 74 days to complete production, so whatever change you make today will not show up in a semen analysis for at least 2 to 3 months. (Amann 2008) Plan accordingly. If you are trying to conceive in the near term, banking sperm before any hormonal change is still the most reliable insurance. A baseline semen analysis before you start anything gives you real data to make decisions from, and is far more useful than guessing based on how you feel.

Get a plan built around your own timeline

Prezerv turns this into a personalized plan (what to test, when to bank, whether hCG fits) in about 60 seconds. No signup to start.

Get my fertility plan →

Common questions

Can I take enclomiphene while staying on TRT to protect fertility?

No, not effectively. Enclomiphene works by unblocking estrogen feedback at the pituitary so your own LH and FSH can rise. When you are on TRT, exogenous testosterone suppresses LH and FSH to 3 to 5 percent of normal regardless of what your estrogen receptors are doing. (Coviello 2005) There is nothing for the enclomiphene to unblock. hCG is the option that works while you are still on testosterone.

Does hCG fully replace TRT, or does it only work as an add-on?

It depends on the cause of your low testosterone. hCG stimulates the testes directly to produce testosterone, so it can work as a stand-alone in secondary hypogonadism, where the problem is insufficient LH signaling rather than testicular failure. For primary hypogonadism, where the testes themselves cannot respond, hCG will not be sufficient on its own. A urologist can run the bloodwork to distinguish which situation applies to you.

How long does it take to see if hCG is working for sperm production?

Sperm take 64 to 74 days to complete the production cycle, so you will not see any meaningful change in a semen analysis for at least 2 to 3 months after starting hCG. (Amann 2008) Testing sooner than that just reflects where you were before the change, not where you are headed.

If I stop TRT and switch to enclomiphene to recover fertility, how long will it take?

After stopping testosterone, median recovery to a fertile sperm concentration is around 3.4 months, with roughly 90 percent of men reaching a fertile count by 12 months. (Liu 2006) Importantly, PCT protocols including SERMs have not been shown to speed up that timeline meaningfully. (Smit 2021) Enclomiphene can help support your axis once TRT is cleared, but the timeline is set more by biology than by the drug.

What if hCG alone is not restoring my sperm count?

hCG replaces the LH signal but does not directly stimulate FSH-dependent spermatogenesis. When hCG alone is not enough, clinicians commonly add an FSH-containing medication (HMG or recombinant FSH) to specifically drive sperm production. That combination induces spermatogenesis in roughly 80 percent of men with hypogonadotropic hypogonadism and achieves pregnancy in about 50 percent. (Rastrelli/Corona 2019) Worth raising with a urologist or REI if you are not seeing results on hCG alone.

More guides

Sources
  • Coviello AD, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-2602.
  • Hsieh TC, et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650.
  • Liu PY, et al. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367(9520):1412-1420.
  • Rastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology. 2014;2(6):794-808. (cited as Rastrelli/Corona 2019 per verified list)
  • Smit DL, et al. Hypothalamic-pituitary-gonadal axis recovery in male AAS users: the HAARLEM study. Hum Reprod. 2021;36(4):880-890.
  • Amann RP. The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl. 2008;29(5):469-487.
  • BSSM (British Society for Sexual Medicine) guidelines on testosterone deficiency. 2025.
  • Wenker EP, Ramasamy R. SERMs for male infertility and hypogonadism. Transl Androl Urol. (cited as Wenker/Ramasamy per verified list)

Prezerv is a self-guided planning tool. It does not provide medical advice, diagnosis, or treatment. Always consult a qualified clinician about your own situation.